02: Research integrity in science
-
Hauptschule
Breakout
/
in englischer SprachePublic trust in science is important. Acts of research misconduct violate this trust, and have an adverse impact on individual perpetrators, their colleagues and institutions, and on those who blow the whistle. It also has ramifications for the knowledge pool, hence wider research community, and entire fields of inquiry. Constructive discussion of this issue necessarily involves scrutiny of a range of questions, some of which are complex and do not lend themselves to ready answers: Who exactly is science for? Is the incidence of fraud on the increase? What sorts of pressures compromise a morally sound research ethos? How can any international rules/guidelines governing research conduct be arrived at or enforced when so many subscribe to the view that moral values are culturally relative? Might education play a role in checking the incidence of research misconduct? If so, what forms should that education take? Who should be involved in policing research? In this workshop, we address these and other questions with a view to contributing constructively to the broader discussion and theme of this year’s Technology Forum.
| |||||
| |||||
| |||||
| |||||
| |||||
| |||||
| |||||
|
Dr. Harvey MARCOVITCH
Editor, Clinical Risk; Associate Editor, BMJ; Chairman, Committee on Publication Ethics (COPE); Chairman General Medical Council Fitness to Practice Panels, Balscote
| 1977-1980 | Consultant paediatrician, North Devon District Hospital, UK |
| Postgraduate Clinical Tutor University of Bristol | |
| 1982-1988 | Postgraduate Clinical Tutor, University of Oxford (North Oxfordshire) |
| 1982-2001 | Consultant paediatrician, Oxford Radcliffe Hospitals NHS Trust, UK |
| 1985-2001 | Honorary clinical senior lecturer, University of Oxford |
| 1994-2002 | Editor, Archives of Disease in Childhood |
MA Ph.D. Brian SALTER
Professor of Politics of Biomedicine and Co-Director, Centre for Biomedicine & Society - CBAS, School of Social Science & Public Policy, King's College London
| 1997-2005 | Professor of Health Services Research, Institute of Health, University of East Anglia |
| 2005-2006 | Economic and Social Research Council (ESRC), Transnational policy learning between the UK and Canada: the case of human genetics |
| 2005-2007 | Professor of Biopolitics, Institute of Health, University of East Anglia |
| 2005-2008 | Economic and Social Research Council (ESRC), Stem Cell Programme: The global politics of human embryonic stem cell regulation |
| 2006-2007 | Economic and Social Research Council (ESRC), Government strategies and commercial models: the politics of the global stem cell bioeconomy |
MD Cand. theol. Dr. phil. Jan Helge SOLBAKK
Chief, Bioethics Section, Division of Ethics of Sciences and Technology, UNESCO, Paris; Professor of Medical Ethics, Section for Medical Ethics, Faculty of Medicine, University of Oslo; Adjunct Professor of Medical Ethics and Philosophy of Medicine, Centre for International Health, Faculty of Medicine, University of Bergen
| 1976-1978 | Studies of Mathematics and Chemistry, University of Trondheim, Norway |
| 1987 | MD, University of Oslo |
| 1989 | Cand. theol (with 'summa cum laude'), University of Oslo |
| 1989-1993 | Dr. phil., University of Oslo |
| 1987-1996 | Director, The National Committee for Medical Research Ethics, The Research Council of Norway |
| 1994-1996 | Adjunct Professor of Medical Ethics, Faculty of Medicine, University of Tromsø, Norway |
| since 1996 | Adjunct Professor of Medical Ethics and Philosophy of Medicine, Centre for International Health, Faculty of Medicine, University of Bergen, Norway |
| Professor of Medical Ethics and Head of Section, Section for Medical Ethics, Faculty of Medicine, University of Oslo | |
| 2007-2008 | Chief of Bioethics Section, UNESCO, Paris |
Dr. Jean-Marie LEHN
Nobel Laureate in Chemistry; Professor, Collège de France, Paris; Director, Laboratoire de Chimie Supramoléculaire at ISIS, Strasbourg
| Studied physical, chemical and natural sciences at the University of Strasbourg | |
| 1960 | Junior Member, Centre National de la Recherche Scientifique, Guy Ourisson's laboratory |
| 1960-1966 | Researcher, Centre National de la Recherche Scientifique (CNRS) |
| 1963 | Thèse de doctorat d'Etat sur la résonance magnétique nucléaire de triterpènes |
| 1964 | Laboratory of Robert Burns Woodward at Harvard University |
| 1966-1969 | Assistant Professor, Chemistry Department of the University of Strasbourg |
| 1970 | Promoted Associate Professor and then Full Professor, Université Louis Pasteur (ULP) of Strasbourg |
| 1970-1979 | Professor, Université Louis Pasteur (ULP) of Strasbourg |
| 1972 | /1974 Visiting professor, Harvard University |
| 1979 | Elected to the chair of "Chimie des Interactions Moléculaires", Collège de France, Paris |
| Professor, Collège de France, Paris | |
| 2002-2004 | Director, Institut de Science et d'Ingénierie Supramoléculaires (ISIS) at ULP, Strasbourg |
M. Phil., M.Sc., BA Hons. Justine BURLEY
Associate Professor and Deputy Executive Director, Graduate School for Integrative Sciences & Engineering (NGS), National University of Singapore
| Post-graduate degrees in both political philosophy, and in neuroscience from the University of Oxford | |
| 1993-2002 | Lecturership at the University of Oxford |
| 1998-2002 | Simon Fellowship at the University of Manchester |
Dr. Alan COLMAN
Principal Investigator, Institute of Medical Biology and Executive Director, Singapore Stem Cell Consortium, Agency for Science, Technology and Research (A*STAR), Singapore; Professor of Regenerative Medicine and Director, Stem Cell Centre, King's College London
| 1974-1976 | Demonstrator in Developmental Biology, Zoology Department, Oxford University |
| 1976-1983 | Lecturer in Department of Biological Sciences, University of Warwick, Coventry |
| 1983-1987 | Senior Lecturer, Department of Biological Sciences, University of Warwick, Coventry |
| 1987-1993 | Professor, Department of Biochemistry, University of Birmingham |
| 1988-1993 | Research Director, PPL Therapeutics plc, Edinburgh, UK (part-time) |
| 1993-2002 | Research Director, PPL Therapeutics plc, Edinburgh, UK (full-time) |
| 2002-2005 | Chief Scientific Officer, ES Cell International, Singapore |
| since 2002 | Adjunct Professor, Department of Biochemistry, National University of Singapore |
| since 2004 | Senior Scientist, Center for Molecular Medicine, Biomedical research Institute, Singapore |
| 2005-2007 | Chief Executive Officer, ES Cell International, Singapore |
| since 2007 | Executive Director of the A*STAR Stem Cell Consortium |
| since 2008 | Professor of Regenerative Medicine and Director of the Stem Cell Centre, King's College, London |
Mag. Johannes HÖHRHAN
Geschäftsführer, Industriellenvereinigung Wien
| 1997-2001 | Studium der Betriebswirtschaftslehre Wirtschaftsuniversität Wien |
| 2001-2005 | Industriellenvereinigung Wien: |
| Assistent der Geschäftsführung | |
| Geschäftsführer der Jungen Industrie Wien | |
| 2004-2010 | Industriellenvereinigung Österreich: |
| Bundesgeschäftsführer der Jungen Industrie Österreich | |
| Vorstandsmitglied in YES Young Entrepreneurs for Europe | |
| 2005-2008 | Industriellenvereinigung Wien: |
| Stellvertretender Geschäftsführer der IV Wien | |
| Geschäftsführer der Jungen Industrie Wien | |
| seit 2007 | Beiratsmitglied EWF-Holding |
| seit 2009 | Industriellenvereinigung Wien: |
| Geschäftsführer der IV Wien |
